16Dec 2017

A REVIEW ARTICLE ON THE FORMATION, MECHANISM AND BIOCHEMISTRY OF MDA AND MDA AS A BIOMARKER OF OXIDATIVE STRESS.

  • Institute of Molecular Biology and Biotechnology, University of Lahore, Pakistan.
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Malondialdehyde (MDA) as a biomarker is widely used for examining oxidative stress in biomedical field where Lipid peroxidation is a chain phenomenon resulting in the formation of various active compounds that result in cellular damage. Bio monitoring of MDA is used as a biomarker in different diseases like in-vivo and in vitro. MDA is also used in various types of diseases like hypertension, diabetes, heart failure and cancer etc. Higher level of MDA was found in patients that suffer from various types of diseases including lung cancer, complex original pain syndrome. In finding the oxidative stress MDA is used as a reliable biomarker. MDA is found in high levels in patients that suffer with goiter. MDA determination can take place by different methods. The determination of MDA was studied in goiter patients through a simple, and rapid but sensitive scientific method. This review is aimed to study the biochemical mechanism of formation of maliondialdehyde and the role of Maliondialdehyde as a biomarker for the diagnosis of several biochemicalcompetition.


  1. T and S.Narumiya (2012).Prostaglandins and chronic inflammation. Trends in Pharmacological Sciences, 33(6): 304?311.
  2. A., M.F Muno, and D.Swarup (2011). Oxidative stress in lead and cadmium toxicity and it amelioration. Vet Med int 2011(2011).
  3. Bielski B.H.J., R. L. Arudi and M. W. Sutherland (1983).A study of the reactivity of HO2/O2- with unsaturated fatty acids. Journal of Biological Chemistry, 258(8):4759?4761.
  4. Baumann J, C. Sevinsky, and D. S. Conklin (2013).Lipid biology of breast cancer. BiochimicaetBiophysicaActa, 1831(10): 1509?1517.
  5. Browne R.Wand D. Armstrong (2000). HPLC analysis of lipidderived polyunsaturated fatty acid peroxidation products in oxidatively modified human plasma. Clinical Chemistry, 46(6):829?836.
  6. Castellani R.J, K. Honda, X. Zhu et al (2004). ?Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease.Ageing Research Reviews, 3(3): 319?326.
  7. Conway S.J and G. J. Miller (2007).Biology-enabling inositol phosphates, phosphatidylinositol phosphates and derivatives. Natural Product Reports, 24(4): 687?707.
  8. Dizdaroglu M and P. Jaruga (2012). Mechanisms of free radicalinduced damage to DNA.Free Radical Research, 46:382?419.
  9. Fruhbeck G., J. G omez-Ambrosi, F. J. Muruzabal, and M. A. Burrell (2001).The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. The American Journal of Physiology: Endocrinology and Metabolism, vol. 280(6): 827?847.
  10. K.N., (1998). Regulation of fatty acid delivery in vivo. Advances in Experimental Medicine and Biology, 441: 171?179.
  11. Fisher S.K, J. E. Novak, and B.W. Agranoff (2002).Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. Journal of Neurochemistry, 82(4):736?754.
  12. G.O, A. Loidl, and A. Hermetter (2007).Oxidized phospholipids: from molecular properties to disease. BiochimicaetBiophysicaActa: Molecular Basis of Disease, 1772(7): 718?736.
  13. C, C. Agnoletto, C. Baldini et al (2010).Redox control of protein kinase C: cell-and disease-specific aspects. Antioxidants and Redox Signaling, 13 (7), 1051?1085.
  14. Hannun Y.A and L. M. Obeid (2008). ?Principles of bioactive lipid signalling: lessons from sphingolipids.Nature Reviews Molecular Cell Biology, 9(2):139?150.
  15. Bwell and J. M. C. Gutteridge, ?Oxygen toxicity, oxygen radicals, transition metals and disease,? Biochemical Journal, 219(1):1?14.
  16. Jornayvaz F.R and G. I. Shulman (2012).Diacylglycerol activation of protein kinase C𝜀 and hepatic insulin resistance. Cell Metabolism, 15(5): 574?584.
  17. P (2012). Regulation of immune responses by prostaglandin E2. Journal of Immunology, 188 (1): 21?28.
  18. Kay J.G., and S. Grinstein (2013). Phosphatidylserine-mediated cellular signaling. Advances in Experimental Medicine and Biology, 99: 177?193.
  19. Kanno T., K. Nakamura, H. Ikai, K. Kikuchi, K. Sasaki, and Y. Niwano (2012). Literature review of the role of hydroxyl radicals in chemically-induced mutagenicity and carcinogenicity for the risk assessment of a disinfection system utilizing photolysis of hydrogen peroxide.Journal of Clinical Biochemistry and Nutrition, vol. 51(1): 9?14.
  20. Kinnunen P.K.J., K. Kaarniranta, and A. K. Mahalka (2012). Proteinoxidized phospholipid interactions in cellular signaling for cell death: from biophysics to clinical correlations.BiochimicaetBiophysicaActa, 1818(10): 2446?2455.
  21. Lipinski B and E. Pretorius (2012).Hydroxyl radical-modified fibrinogen as a marker of thrombosis: the role of iron. Hematology, 17(4):241?247.
  22. Lane N (2002). Oxygen: The Molecule that Made the World, Oxford University Press.
  23. Massey K.A., and A. Nicolaou (2011). Lipidomics of polyunsaturatedfatty-acid-derived oxygenated metabolites. Biochemical Society Transactions, vol. 39(5)1240?1246.
  24. Massey K.A and A. Nicolaou (2013).Lipidomics of oxidized polyunsaturated fatty acids. Free Radical Biology and Medicine, 59: 45?55 .
  25. Mattson M.P (2003). Membrane Lipid Signaling in Aging and AgeRelated Disease. Elsevier , 12: 263.
  26. Moldovan L and N. I. Moldovan (2004).Oxygen free radicals and redox biology of organelles. Histochemistry and Cell Biology, 122(4) : 395?412.
  27. Pluchino .N., M. Russo, A. N. Santoro, P. Litta, V. Cela, and A. R. Genazzani(2013).Steroid hormones and BDNF. Neuroscience, 239: 271?279.
  28. Reis A and C. M. Spickett (2012).Chemistry of phospholipid oxidation. BiochimicaetBiophysicaActa, 1818(10):2374? 2387.
  29. Schneider C., W. E. Boeglin, H. Yin, N. A. Porter, and A. R. Brash (2008). Intermolecular peroxyl radical reactions during autoxidation of hydroxy and hydroperoxyarachidonic acids generate a novel series of epoxidized products. Chemical Research in Toxicology, 21(4): 895?903.
  30. Takuwa Y, Y. Okamoto, K. Yoshioka, and N. Takuwa, (2012).Sphingosine-1-phosphate signaling in physiology and diseases. Bio Factors, 38 (5): 329?337.
  31. Tang E.H.C, P. Libby, P. M. Vanhoutte, and A. Xu (2012).Antiinflammation therapy by activation of prostaglandin EP4 receptor in cardiovascular and other inflammatory diseases. Journal of Cardiovascular Pharmacology, 59(2): 116?123.
  32. Vance E and J. E. Vance (2002). Biochemistry: Biochemistry of Lipids. Lipoproteins and Membranes, 4th edition.
  33. Venero J.L, M. Revuelta, L. Atiki et al (2003) .Evidence for dopamine derived hydroxyl radical formation in the nigrostriatal system in response to axotomy. Free Radical Biology and Medicine, 34(1):111?123.
  34. Yin H, L. Xu, and N. A. Porter (2011).Free radical lipid peroxidation: mechanisms and analysis. Chemical Reviews, 111(10): 5944?5972.
  35. Volinsky R and P. K. J. Kinnunen (2013). Oxidized phosphatedylcholines in membrane-level cellular signaling: from biophysics to physiology and molecular pathology. FEBS Journal, 280(12):2806?2816.
  36. Yang C and M. G. Kazanietz (2007). Chimaerins: GAPs that bridge diacyl glycerol signalling and the small G-protein Rac. Biochemical Journal, 403(1):1?12.

[Saima Jadoon and Arif Malik. (2017); A REVIEW ARTICLE ON THE FORMATION, MECHANISM AND BIOCHEMISTRY OF MDA AND MDA AS A BIOMARKER OF OXIDATIVE STRESS. Int. J. of Adv. Res. 5 (Dec). 811-818] (ISSN 2320-5407). www.journalijar.com


Saima Jadoon
University of Lahore, Pakistan

DOI:


Article DOI: 10.21474/IJAR01/6024      
DOI URL: https://dx.doi.org/10.21474/IJAR01/6024